BridgeMD
Tests treatment safety and results for Frozen Shoulder
Official title Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis
ClinicalTrials.gov ID: NCT07493226
What this study is testing
What is Propionic acid deriaves?
Propionic acid deriaves is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for frozen shoulder.
Also referred to as İbuprofen, naproksen.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients aged 18-75 years who present to a tertiary rehabilitation hospital with shoulder pain and restricted range of motion, and who consent to participate, will be included in the study. Eligibility will be determined based on predefined inclusion and exclusion criteria.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Being between 18-75 years of age
- Having shoulder pain that has lasted for at least one month and being diagnosed with primary frozen shoulder
- Having a VAS pain level ≥ 4/10
- Having ≥30 degrees of range of motion restriction in at least two planes (flexion, abduction, or external rotation)
- Not having any
You likely can't join if
- and agreeing to participate in the study voluntarily Exclusion Criteria:
- Patients with a history of shoulder trauma, those with musculoskeletal disorders characterized by pain and loss of function in the affected extremity...
- Presence of neurological involvement such as stroke, brachial plexus injury, Parkinson's disease, and cervical spine injury with or without...
- History of shoulder surgery, malignancy or tumor in the shoulder, those who have undergone shoulder manipulation
- Presence of shoulder arthritis, rotator cuff tear or other shoulder injuries, thoracic outlet syndrome
- Systemic disease affecting the shoulder region, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, history of labrum or...
See the full eligibility criteria
- Being between 18-75 years of age
- Having shoulder pain that has lasted for at least one month and being diagnosed with primary frozen shoulder
- Having a VAS pain level ≥ 4/10
- Having ≥30 degrees of range of motion restriction in at least two planes (flexion, abduction, or external rotation)
- Not having any
- and agreeing to participate in the study voluntarily Exclusion Criteria:
- Patients with a history of shoulder trauma, those with musculoskeletal disorders characterized by pain and loss of function in the affected extremity (such as lateral epicondylitis, flexor tendon injury, de Quervein's...
- Presence of neurological involvement such as stroke, brachial plexus injury, Parkinson's disease, and cervical spine injury with or without radiculopathy
- History of shoulder surgery, malignancy or tumor in the shoulder, those who have undergone shoulder manipulation
- Presence of shoulder arthritis, rotator cuff tear or other shoulder injuries, thoracic outlet syndrome
- Systemic disease affecting the shoulder region, severe degeneration or trauma (e.g., osteoarthritis, rheumatoid arthritis, history of labrum or articular cartilage injuries), inflammatory rheumatic diseases
- Those who have received steroid injections into the affected extremity within the last 3 months, those using oral steroids or NSAIDs, those receiving any surgical or treatment treatment, or Planned individuals:
- Those who are pregnant or lactating
- Those with uncontrolled diabetes, heart failure, uncontrolled systemic disease (liver disease, chronic kidney failure, significant endocrine disorders, etc.)
- Those with communication problems, severe psychiatric disorders
- Those allergic to NSAIDs or with any contraindications
- Those with bleeding, coagulation disorders, stomach ulcers, or symptomatic gastritis
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Selçuklu, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Selçuklu, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.